奥姆尼艾比生物

最新新闻

• 评级变动
  A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $5 to $11
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $3 to $11
  \u5e02\u573a\u8d44\u8baf · 2025/8/8
• 评级变动
  Leerink Partners Maintains OmniAb(OABI.US) With Buy Rating, Raises Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2025/5/16
• 评级变动
  TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $4
  \u5e02\u573a\u8d44\u8baf · 2025/8/7
• 评级变动
  TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $3
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• Analysts Are Bullish on These Healthcare Stocks: CapsoVision, Inc. (CV), OmniAb (OABI)
  TipRanks · 2026/9/30
• 评级变动
  Benchmark Co. Maintains OmniAb(OABI.US) With Buy Rating, Cuts Target Price to $4
  \u5e02\u573a\u8d44\u8baf · 2025/11/6
• Stifel Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $9
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Sionna Therapeutics, Inc. (SION), OmniAb (OABI) and Astrana Health (ASTH)
  TipRanks · 2026/3/3
• 评级变动
  A Quick Look at Today's Ratings for OmniAb(OABI.US), With a Forecast Between $7 to $11
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• Truist Financial Maintains OmniAb(OABI.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/8/18
• 评级变动
  Craig-Hallum Maintains OmniAb(OABI.US) With Buy Rating, Announces Target Price $7
  \u5e02\u573a\u8d44\u8baf · 2026/5/8
• 评级变动
  Stifel Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2025/8/7
• 评级变动
  TR | OpenAI - 4o Initiates OmniAb(OABI.US) With Hold Rating, Announces Target Price $2
  \u5e02\u573a\u8d44\u8baf · 2025/8/11
• H.C. Wainwright Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP)
  TipRanks · 2026/8/17
• 评级变动
  Stifel Maintains OmniAb(OABI.US) With Buy Rating, Cuts Target Price to $9
  \u5e02\u573a\u8d44\u8baf · 2025/11/6
• 评级变动
  Benchmark Co. Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $6
  \u5e02\u573a\u8d44\u8baf · 2025/8/9
• Craig-Hallum Maintains OmniAb(OABI.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  H.C. Wainwright Keeps Their Buy Rating on OmniAb (OABI)
  TipRanks · 2026/8/17

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。